Galdu-irabazien kontua
THERIVA BIOLOGICS, INC.
TOVX
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 |
|
Diru-sarreren kostua
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi gordina
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-gastuak
|
24.05 | 26.35 | 21.43 | 21.58 | 14.27 | 10.16 | 15.66 | 17.57 | 26.25 | 39.25 | 40.98 | 20.50 | 12.34 | 17.30 | 5.93 |
|
Ikerketa eta garapena
|
8.60 | 12.03 | 14.31 | 11.72 | 7.80 | 5.13 | 11.08 | 11.84 | 18.78 | 29.11 | 32.91 | 14.49 | 6.51 | 12.29 | 3.34 |
|
Salmentak, orokorrak eta administratiboak
|
15.45 | 7.40 | 7.12 | 9.86 | 6.47 | 5.03 | 4.58 | 5.73 | 7.47 | 10.14 | 8.07 | 6.01 | 5.83 | 5.01 | 2.59 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-24.05 | -26.35 | -21.43 | -21.58 | -14.27 | -10.16 | -15.66 | -17.57 | -26.25 | -39.25 | -40.98 | -20.50 | -12.34 | -17.30 | -5.93 |
|
Ez-ustiapeneko diru-sarrerak
|
0.31 | 0.69 | 1.44 | 0.47 | 0.01 | 0.04 | 0.28 | 4.15 | 10.76 | 11.45 | -3.81 | 0.72 | 0.02 | 0.02 | -1.70 |
|
Interesen diru-sarrerak
|
0.29 | 0.70 | 1.44 | 0.51 | 0.01 | 0.04 | 0.28 | 0.07 | 0.02 | 0.04 | 0.01 | 0.00 | 0.03 | 0.03 | 0.01 |
|
Interesen gastuak
|
0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.10 | -0.01 | -0.02 | - |
|
Zerga aurreko irabazia
|
-23.74 | -25.65 | -19.99 | -21.11 | - | - | - | - | - | - | - | - | -12.34 | -17.30 | -5.93 |
|
Zerga-gastua
|
- | 0.00 | -1.64 | -1.43 | - | - | - | - | - | - | - | - | -0.02 | -0.23 | 2.22 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | 0.00 | 0.10 | 2.80 | 2.90 | 2.90 | 0.55 | 0.55 | 1.30 | 0.00 | 0.00 | - | - |
|
Irabazi garbia
|
-23.70 | -25.65 | -18.35 | -19.69 | -14.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -19.78 | -12.32 | -17.07 | -8.15 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-23.94 | -26.21 | -21.30 | -21.50 | -14.19 | -9.96 | -15.42 | -17.30 | -26.01 | -39.10 | -40.91 | -20.50 | -12.34 | -17.30 | -5.93 |
|
Akzioko irabazia (oinarrizkoa)
|
-2.08 | -19.03 | -1.14 | -1.31 | -0.19 | - | - | - | - | - | - | - | - | - | - |
|
EPS diluitua
|
-2.08 | -19.03 | -1.14 | -1.31 | -0.19 | - | - | - | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatua
|
12.14 | 1.35 | 16.11 | 15.33 | 121.88 | - | - | - | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
12.14 | 1.35 | 16.11 | 15.33 | 121.88 | - | - | - | - | - | - | - | - | - | - |
|
Irabazi globala
|
- | - | - | -20.36 | - | - | - | - | - | - | - | - | - | - | - |